๐ข Great news for ST3 Urology NTN applicants.
Publications in Trends in Urology & Menโs Health are now recognised within NTN portfolio scoring.
Collaborate with us and help advance Menโs Health.
Submit your manuscript today!
@BSoT_UK#Urology#ST3#MensHealth
New in Trends, Home of Menโs Health:
Awareness of #LUTS remains low in primary care.
In a HK study of 450 men aged โฅ40:
โข 29.3% had heard of LUTS
โข 31.8% had adequate knowledge
Improvements in patient education is needed.
๐: https://t.co/IcVRZ12lKh
#Trends#MensHealth
New in Trends, Home of Menโs Health:
A systematic review comparing dapoxetine & clomipramine for premature ejaculation found both treatments improved IELT & patient satisfaction, with differing efficacy & tolerability profiles.
๐: https://t.co/VjDqwQ3paY
#MensHealth#Trends
Have you entered yet? ๐
Head to the post below for your chance to win a book of your choice up to $50 and learn why @TrendsMenHealth could be a great fit for your research.
Enter by 3/30/26.
New in #Trends ๐:
A post-marketing study of Novoglan 1st & 2nd gen shows:
โ Efficacy โ 85% โ 93.5%
โ Usability improved
โ 98% would recommend
โ No significant adverse effects
A promising option for phimosis management.
#Urology#Andrology
New in Trends, the Home for Men's Health:
Can we reduce unnecessary cystoscopies? ๐
Explore how Cxbladder is reshaping haematuria and surveillance pathways with high rule-out accuracy.
๐ Read more with @TrendsMenHealth#Urology#BladderCancer#Diagnostics
Giveaway time ๐
Discover why Trends in Urology & Menโs Health could be the right journal for your next submission.
Follow @WileyHealth and @TrendsMenHealth and tag a fellow early career researcher for a chance to win a book up to $50.
๐ Enter the giveaway by 3/30/26.
Testosterone therapy has entered a new era!
Following the 2023 TRAVERSE trial and FDA removal of black box warnings (2025), clinical practice has shifted from categorical caution to individualized assessment.
Read the full review: https://t.co/7gppG90iN0
#TRAVERSE#MensHealth
Residual fragments after ESWL or RIRS remain a persistent challenge.
This SRMA (n=1,026) demonstrates that adjunctive EPVL/PDI significantly improve stone-free rates at 1, 2 & 4 weeks without increasing complications.
Read more: https://t.co/9NptG1RqFo
#Urology#KidneyStones
Delighted to announce the publication of the BAUS consensus document on male genital augmentation and enhancement procedures.
Appraisal of safety and efficacy combining 36 studies involving 3,748 patients
๐ฒ Read the consensus statement in full: https://t.co/MoSuX9pjFj
[1/4]
๐ฅ New in @TrendsMenHealth, The Home for Men's Health:
Scrotal trauma, though rare, can have lasting effects on fertility, hormonal function, and psychological health.
This practical guide for urologists reviews mechanisms, acute management, and reconstruction.
#MensHealth https://t.co/kj7wUHFlf4
๐ New in @TrendsMenHealth, The Home for Men's Health:
Following Dobbs v. Jackson Womenโs Health Organization, U.S. Google searches for reproductive procedures surged especially for hysterectomy & vasectomy.
๐https://t.co/bdx964rAmY
#MensHealth#Fertility#ReproductiveMedicine
๐ New in Trends, The Home for Men's Health:
A 2025 update on TRT from the landmark TRAVERSE trial to evolving formulations, monitoring, and precision approaches.
The era of individualized TRT is here.
๐: https://t.co/Cq5vbbJ1gQ
#MensHealth#Testosterone